Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 42Uterine Cervical Neoplasms 41Breast Neoplasms 10Vaginal Neoplasms 6Neoplasms 6Endometrial Neoplasms 6Liver Neoplasms 5Uterine Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Vulvar Neoplasms 3Retinoblastoma 3Radiation Injuries 3Ovarian Neoplasms 3Hyperthermia 3Carcinoma, Hepatocellular 3Adenocarcinoma 3Rhabdomyosarcoma 2Rectal Neoplasms 2Melanoma 2Head and Neck Neoplasms 2Gynecologic Cancer 2Desmoplastic Small Round Cell Tumor 2Deglutition Disorders 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uveal Melanoma 1

Interventions

Radiosurgery 2Radiotherapy, Intensity-Modulated 1Radiation 1Proton Therapy 1Nivolumab 1Dihematoporphyrin Ether 1Cesium-131 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrent Head and Neck Carcinoma × Brachytherapy × Clear all
NCT02467738 2025-09-19

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
30 enrolled
Head & Neck

Recurrent Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡